Application 078302
- Type
- ANDA
- Sponsor
- OXFORD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | TABLET;ORAL | 30MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078302-001 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2007-12-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078302-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078302-001 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2007-12-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078302-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 476f4f55-c6c1-4f39-950e-59236f499577 | 2026-03-18 | Warnings, Adverse reactions | 078302 ANDA078302 72789-142 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Proficient Rx LP | 1521109d-8386-472f-9483-f1fe9f7ed152 | 2026-01-01 | Warnings, Adverse reactions | 078302 ANDA078302 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | eb072818-3ca8-430b-91a1-e7fedd37990c | 2025-11-04 | Warnings, Adverse reactions | 078302 ANDA078302 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 38677cd0-2ee6-4c8f-8553-36310b2813a1 | 2025-11-02 | Warnings, Adverse reactions | 078302 ANDA078302 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 790b6159-c03b-4a3a-be6b-add35a3114a4 | 2025-10-03 | Warnings, Adverse reactions | 078302 ANDA078302 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Oxford Pharmaceuticals, LLC | 97fcebc1-6615-4b9d-b0f3-6434850f407c | 2025-08-14 | Warnings, Adverse reactions | 078302 ANDA078302 69584-094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 696911d8-e97a-4c8e-9341-782b4c63bf03 | 2024-08-12 | Warnings, Adverse reactions | 078302 ANDA078302 63629-2415 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 8bb7991e-ab09-4602-b49d-0a72a501685b | 2024-08-06 | Warnings, Adverse reactions | 078302 ANDA078302 63629-2414 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 63629-2414 | Buspirone Hydrochloride | buspirone hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-2414 | Buspirone Hydrochloride | buspirone hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-2415 | Buspirone Hydrochloride | buspirone hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-2415 | Buspirone Hydrochloride | buspirone hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 69584-094 | Buspirone Hydrochloride | buspirone hydrochloride | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-094 | Buspirone Hydrochloride | buspirone hydrochloride | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-094 | Buspirone Hydrochloride | buspirone hydrochloride | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-094 | Buspirone Hydrochloride | buspirone hydrochloride | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 72789-142 | Buspirone Hydrochloride | buspirone hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-142 | Buspirone Hydrochloride | buspirone hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-142 | Buspirone Hydrochloride | buspirone hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |